Allina Health   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Minneapolis MN United States (1994)

Organization Overview

First Clinical Trial
2007
NCT00564772
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Allina Health | Allina Health Services | Allina Health System | Allina Hospitals and Clinics | United Medical Specialties

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cholangiocarcinoma (Phase 2)

Communicable Diseases (Phase 2)

Infections (Phase 2)

Insulin Resistance (Phase 2)

Metabolic Syndrome (Phase 2)

Spinal Stenosis (Phase 4)

Spondylolisthesis (Phase 4)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 13